发表主要论著 |
1、G Wang, Y Zhong, J Liang, Z Li, Y Ye. Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma[J]. PeerJ, 2020, 8:e8625. 2、X Liu,X Yang,X Chen,Y Zhang,X Pan,G Wang,Y Ye. Expression profiling identifies bezafibrate as potential therapeutic drug for lung adenocarcinoma[J], J Cancer, 2015, 6(12): 1214-1221. 3、Guiping, W. , Yun, Y. , Xiaoqin, Y. , Hongying, L. , Canguo, Z. , & Shuang, L. Expression-Based In Silico Screening of Candidate Therapeutic Compounds for Lung Adenocarcinoma[J]. PLos One, 2011, 6(1): 0-e14573 4、高强,钟英英,丁华杰,叶云.肺腺癌相关基因的生物信息学分析[J].中国肿瘤生物治疗杂志, 2019, 26(02): 190-195. 5、丁华杰,叶云,安欢,高强,钟英英.肺腺癌关键基因的表达及其预后意义[J].中国比较医学杂志, 2019, 29(10): 54-60. 6、叶云,钟英英,孙宇飞,张倩.乳腺癌外周血中分子检测标记的筛选[J].肿瘤防治研究, 2015, 42(07): 657-661. 7、叶云,黄临凌,钟英英,孙宇飞,张倩.乳腺癌复发相关基因预测疾病的特异生存率研究[J]. 肿瘤防治研究, 2016, 43(09):762-766. |